-Peer-Reviewed Study, bioAffinity Technologies CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis

Press/Media

Period19 Sep 2024

Media coverage

2

Media coverage

  • Title-Peer-Reviewed Study, bioAffinity Technologies CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date19/09/24
    PersonsMichael Morris
  • Title-Peer-Reviewed Study, bioAffinity Technologies CyPath Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date19/09/24
    PersonsMichael Morris
View all 2
View less